Study of median effective effect-site concentration of sufentanil for analgesic in adolescents undergoing surgery for idiopathic scoliosis with intraoperative wake-up test

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TTRCC-12002696

Enrollment

Unknown

Registered

2012-11-09

Start date

2011-05-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent idiopathic scoliosis

Interventions

6:effect-site concentration of sufentanil

Eligibility

Sex/Gender

All

Age

13 Years to 18 Years

Inclusion criteria

Inclusion criteria: Sixty ASA I patients, aged 13-18 yr, scheduled for adolescent idiopathic scoliosis surgery.

Exclusion criteria

Exclusion criteria: BMI >=25 kg/m2

Design outcomes

Primary

Measure	Time frame
effect-site concentration of sufentanil;	—

Countries

China

Contacts

Public ContactCheng-Hua Zhang

mizhouyn@tom.com+86 13150755240

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 5, 2026